Previous close | 16.25 |
YTD return | N/A |
Expense ratio (net) | N/A |
Category | N/A |
Last cap gain | N/A |
Morningstar rating | N/A |
Morningstar risk rating | N/A |
Sustainability rating | N/A |
Net assets | N/A |
Beta (5Y monthly) | N/A |
Yield | N/A |
5y average return | N/A |
Holdings turnover | N/A |
Last dividend | N/A |
Average for category | N/A |
Inception date | N/A |
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'll want to see a proven...
Key Insights Using the 2 Stage Free Cash Flow to Equity, Dr. Hönle fair value estimate is €32.45 Dr. Hönle is estimated...
While Dr. Hönle AG ( ETR:HNL ) might not have the largest market cap around , it saw a significant share price rise of...